InsidersTradesSigma
Discover the full record of transactions filed by 홍성상, Chief Executive Officer. Insider active across 2 companies, notably 경보제약. In total, 2 filings have been logged. The latest transaction was filed on 17 March 2026 — Purchase. Regulator: DART (FSS). The full history is accessible without signup.
2 of 2 declarations
Hong Sung-Sang is the Managing Director of 경보제약, a pharmaceutical company. In this role, he oversees operations and research projects, contributing to the innovation and growth of the company. His expertise is essential for the success of strategic initiatives.